Literature DB >> 23235198

Consumption of whole grain reduces risk of deteriorating glucose tolerance, including progression to prediabetes.

Tina Wirström1, Agneta Hilding, Harvest F Gu, Claes-Göran Östenson, Anneli Björklund.   

Abstract

BACKGROUND: High whole-grain intake has been reportedly associated with reduced risk of developing type 2 diabetes (T2D), which is an effect possibly subject to genetic effect modification. Confirmation in prospective studies and investigations on the impact on prediabetes is needed.
OBJECTIVES: In a prospective population-based study, we investigated whether a higher intake of whole grain protects against the development of prediabetes and T2D and tested for modulation by polymorphisms of the TCF7L2 gene.
DESIGN: We examined the 8-10-y incidence of prediabetes (impaired glucose tolerance, impaired fasting glucose, or the combination of both) and T2D in relation to the intake of whole grain. Baseline data were available for 3180 women and 2297 men aged 35-56 y.
RESULTS: A higher intake of whole grain (>59.1 compared with <30.6 g/d) was associated with a 34% lower risk to deteriorate in glucose tolerance (to prediabetes or T2D; women and men combined). The association remained after adjustments for age, family history of diabetes, BMI, physical activity, smoking, education, and blood pressure (OR: 0.78; 95% CI: 0.63, 0.96). Risk reduction was significant in men (OR: 0.65; 95% CI: 0.49, 0.85) but not in women. Associations were significant for prediabetes per se (all, OR: 0.73; 95% CI: 0.56, 0.94; men, OR: 0.57; 95% CI: 0.40, 0.80). The intake of whole grain correlated inversely with insulin resistance (HOMA-IR). The impact of whole-grain intake was undetectable in men who harbored diabetogenic polymorphisms of the TCF7L2 gene.
CONCLUSIONS: A higher intake of whole grain is associated with decreased risk of deteriorating glucose tolerance including progression from normal glucose tolerance to prediabetes by mechanisms likely tied to effects on insulin sensitivity. Effect modifications by TCF7L2 genetic polymorphisms are supported.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23235198     DOI: 10.3945/ajcn.112.045583

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  32 in total

1.  Dietary fiber intake and risk of type 2 diabetes: a dose-response analysis of prospective studies.

Authors:  Baodong Yao; Hong Fang; Wanghong Xu; Yujie Yan; Huilin Xu; Yinan Liu; Miao Mo; Hua Zhang; Yanping Zhao
Journal:  Eur J Epidemiol       Date:  2014-01-05       Impact factor: 8.082

Review 2.  Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies.

Authors:  Dagfinn Aune; Teresa Norat; Pål Romundstad; Lars J Vatten
Journal:  Eur J Epidemiol       Date:  2013-10-25       Impact factor: 8.082

3.  A whole-grain diet reduces peripheral insulin resistance and improves glucose kinetics in obese adults: A randomized-controlled trial.

Authors:  Steven K Malin; Emily L Kullman; Amanda R Scelsi; Jacob M Haus; Julianne Filion; Mangesh R Pagadala; Jean-Philippe Godin; Sunil Kochhar; Alastair B Ross; John P Kirwan
Journal:  Metabolism       Date:  2018-01-03       Impact factor: 8.694

4.  Postprandial effects of test meals including concentrated arabinoxylan and whole grain rye in subjects with the metabolic syndrome: a randomised study.

Authors:  M L Hartvigsen; H N Lærke; A Overgaard; J J Holst; K E Bach Knudsen; K Hermansen
Journal:  Eur J Clin Nutr       Date:  2014-03-05       Impact factor: 4.016

5.  The impact of cereal grain consumption on the development and severity of non-alcoholic fatty liver disease.

Authors:  Michael Georgoulis; Meropi D Kontogianni; Nafsika Tileli; Aikaterini Margariti; Elisabeth Fragopoulou; Dina Tiniakos; Rodessa Zafiropoulou; George Papatheodoridis
Journal:  Eur J Nutr       Date:  2014-03-07       Impact factor: 5.614

Review 6.  Practical Dietary Recommendations for the Prevention and Management of Nonalcoholic Fatty Liver Disease in Adults.

Authors:  Elena S George; Adrienne Forsyth; Catherine Itsiopoulos; Amanda J Nicoll; Marno Ryan; Siddharth Sood; Stuart K Roberts; Audrey C Tierney
Journal:  Adv Nutr       Date:  2018-01-01       Impact factor: 8.701

7.  Effects of concentrated arabinoxylan and β-glucan compared with refined wheat and whole grain rye on glucose and appetite in subjects with the metabolic syndrome: a randomized study.

Authors:  M L Hartvigsen; S Gregersen; H N Lærke; J J Holst; K E Bach Knudsen; K Hermansen
Journal:  Eur J Clin Nutr       Date:  2013-11-20       Impact factor: 4.016

Review 8.  Systematic Review and Meta-Analysis of Human Studies to Support a Quantitative Recommendation for Whole Grain Intake in Relation to Type 2 Diabetes.

Authors:  Aurelie Chanson-Rolle; Alexandra Meynier; François Aubin; Jenni Lappi; Kaisa Poutanen; Sophie Vinoy; Veronique Braesco
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

9.  Dietary fibre and incidence of type 2 diabetes in eight European countries: the EPIC-InterAct Study and a meta-analysis of prospective studies.

Authors: 
Journal:  Diabetologia       Date:  2015-05-29       Impact factor: 10.122

10.  Increasing whole grain intake as part of prevention and treatment of nonalcoholic Fatty liver disease.

Authors:  Alastair B Ross; Jean-Philippe Godin; Kaori Minehira; John P Kirwan
Journal:  Int J Endocrinol       Date:  2013-05-16       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.